Table 2.
Comparison of biomarker expression in blood and tissue samples.
| Control healthy subjects |
Breast cancer patients |
||||
|---|---|---|---|---|---|
| Blood (n = 50) |
Blood (n = 64) |
Tissue (n = 64) |
|||
| Biomarker | N(+) | N(+) | N(+) | P1 | P2 |
| CEA(O) | 11 | 33 | 25 | 0.001∗ | NS |
| erbB2 | 6 | 30 | 51 | 0.000∗ | 0.000∗ |
| MAM | 18 | 30 | 27 | NS | NS |
| ERβ | 0 | 13 | 16 | 0.001∗ | NS |
| CK19 | 37 | 63 | 61 | 0.000∗ | NS |
| Ki67 | 22 | 10 | 56 | 0.001∗ | 0.000∗ |
| CEA(i) | 40 | 45 | 39 | NS | NS |
| Muc | 44 | 56 | 62 | NS | 0.000٭ |
| c-Myc | 4 | 31 | 26 | 0.000∗ | NS |
P1: Chi-Square test was used between the blood of healthy individual and breast cancer patients; P2: Chi-Square test was used between the blood and the tumor of breast cancer patients; ∗: Significant at 0.05(p < 0.05); NS: Non Significant.